(2,121) --- (2,121) ---
--------- --------- --------- ---------
(LOSS) BEFORE
INCOME TAXES (2,860,019) (2,333,696) (5,981,688) (4,148,355)
Income taxes --- --- --- ---
--------- --------- --------- ---------
NET (LOSS) $(2,860,019) $(2,333,696) $(5,981,688) $(4,148,355)
=========== =========== =========== ===========
Basic and
diluted net
(loss) per
common share $(0.04) $(0.04) $(0.09) $(0.07)
====== ====== ====== ======
WEIGHTED
AVERAGE NUMBER
OF COMMON
SHARES
OUTSTANDING 65,602,990 62,466,881 65,564,354 62,445,519
========== ========== ========== ==========
ULURU Inc.
SELECTED CONDENSED CONSOLIDATED BALANCE SHEET DATA
June 30, December 31,
2009 2008
(Unaudited) (Audited)
------------ ---------
Cash and cash equivalents $1,710,005 $7,567,588
Current assets 4,277,214 9,312,041
Property and equipment, net 1,731,536 1,828,040
Other assets 9,457,670 9,985,988
Total assets 15,466,420 21,126,069
Current liabilities 1,320,928 2,243,113
Long term liabilities
- deferred revenue 1,306,950 1,356,526
'/>"/>
SOURCE ULURU Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 Related medicine news :1.
ULURU Inc. to Present at UBS Global Life Sciences Conference 20072.
ULURU Inc. Announces Odd-Lot Buy Back Offer3.
ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2007 and Provide a Business Update4.
ULURU Inc. Reports Third Quarter 2007 Results5.
ULURU Inc. Announces Issuance of Notice of Allowance for Nanoparticle Aggregate Patent6.
ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 20087.
ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2008 and Provide a Business Update8.
ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter Ended December 31, 2007 and Provide a Business Update9.
ULURU Inc. Announces the Launch Plan for Altrazeal(TM)10.
ULURU Inc. Reports First Quarter 2008 Financial Results11.
ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of Directors